Solution Circle: What can manufacturers learn from effective PMS/PMPF strategies to strengthen their Clinical Evidence with the IVDR transition deadline approaching?
12:30 – 13:00 CEST
Solutions Circle: What Can Manufacturers Learn From Effective PMS/PMPF Strategies to Strengthen Their Clinical Evidence With The IVDR Transition Deadline Approaching?
Randomized Clinical Trials vs. Validation Cohort studies of AI/ML-based SaMDs: what are the differences and guidelines for appraisal of the clinical evidence?
13:45 – 14:45 CEST
Randomized Clinical Trials vs. Validation Cohort Studies of AI/ML-Based SaMDs: What Are the Differences and Guidelines for Appraisal of the Clinical Evidence?